CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Best Practice Alert +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07580482
NCT07580482N/ACompleted

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

University of Kansas Medical Center·interventional·Posted May 12, 2026·Updated May 12, 2026

In Brief

A clinical study evaluating Best Practice Alert and No Intervention for Liver Diseases and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to promote the diagnosis and awareness of Non-Alcoholic Steatohepatitis (NASH) by linkage of care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsGilead Sciences

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 12, 2026
Enrollment StartJul 15, 2020
Primary CompletionJul 15, 2022
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 2 months ago

Interventions

Best Practice Alertbehavioral

To determine if rates of screening and referral to hepatology can be improved through an EMR-based BPA for an appropriate referral.

No Interventionbehavioral

The only intervention is the Best Practice Alert (BPA). Providers from three departments will be randomized to one of two groups: one that receives a BPA and one that does not. Thereafter, the study will observe patients who fit criteria for NASH referral, as defined by a diagnosis of T2DM and appropriate Fib4 score to determine if they have been referred to Hepatology for assessment.